GS-100 - Nayrïr NGLY1 jan walt'awin usuta

GS-100 - Nayrïr NGLY1 jan walt'awin usuta

Clinical Trials Arena

GS-100 ukax mä recombinante AAV9 vector ukjamawa, NGLY1 gen ukamp chika. FDA uksatx mä droga orfán ukhamaw uñt'ayata, ukjamarus akax mä usu usu usu usu ukjamarakiwa.

#SCIENCE #Central Aymara #CU
Read more at Clinical Trials Arena